US government secures 100m doses of GSK and Sanofi vaccine for $2.1bn 03-Aug-2020 By Ben Hargreaves In return for capital for development and manufacturing scale-up help, Sanofi and GSK agree number of doses of potential COVID-19 vaccine.
How much is COVID-19 vaccine worth? $2bn per 100m doses 22-Jul-2020 By Ben Hargreaves US government agrees a deal for 100m doses of potential vaccine, with option to take further 500m order.
Regeneron COVID-19 antibody cocktail enters late-stage trials 07-Jul-2020 By Ben Hargreaves Regeneron’s potential coronavirus treatment enters Phase III and US government provides capital injection for manufacture.
US government doubles down with $143m syringe investment 09-Jun-2020 By Ben Hargreaves Ramping up preparedness for potential COVID-19 vaccine, the US government awards SiO2 a contract for syringe and vials.
US pushes forward five vaccine candidates 04-Jun-2020 By Ben Hargreaves Reports suggest US government has selected five companies with the most promising vaccine leads to be given additional financial and infrastructure support.
Sanofi retracts US-first stance on COVID-19 vaccine 18-May-2020 By Ben Hargreaves The French company bows to pressure from the French government to state that there will be no preferential supply to US of potential vaccine.
US outlines plan for readying coronavirus vaccine by start of 2021 18-May-2020 By Ben Hargreaves The US government provided details on ‘Operation Warp Speed’ and who will take leadership of the project.
US strikes $138m deal to ensure enough syringes for COVID-19 vaccine 13-May-2020 By Ben Hargreaves US HHS provides funding in order to boost the number of prefilled syringes available for potential vaccine against coronavirus.
